Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Sdgla who wrote (1381652)	12/1/2022 4:11:40 PM
From: Wharf Rat	1 Recommendation Recommended By pocotrader Read Replies (1) \| Respond to of 1575930

quack quack SciCheck Digest Randomized clinical trials have repeatedly found that ivermectin does not benefit COVID-19 patients. The National Institutes of Health recommends against its use for COVID-19. Ivermectin enthusiasts continue to falsely claim the contrary. factcheck.org == Blogger bungles analysis of Swiss COVID figures William Summers November 25, 2022 WHAT WAS CLAIMED A graph showing Swiss COVID-19 mortality proves hydroxychloroquine is an effective treatment for the virus. THE VERDICT The claim that Swiss COVID data proves hydroxychloroquine is an effective treatment for the virus is false. The claim was based on data analysis by a French website but the figures do not match official Swiss COVID death numbers. Regardless of the accuracy of the data, biostatisticians told AAP FactCheck the website's analysis and interpretation of a small sample of data was a poor way to assess the effectiveness of hydroxychloroquine. Multiple scientific studies have found it to be ineffective against COVID. False - The claim is inaccurate. aap.com.au